Pioglitazone trials for Type 2 diabetes

All Pioglitazone trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Pioglitazone for Type 2 diabetes

• Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
  NCT06246799 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
  NCT05028140 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
  NCT06399835 · Phase: Phase 4 · Ages: 20 Years to 80 Years · Sex: All (male and female) · 1 location
• Low-Dose Pioglitazone in Patients With NASH (AIM 2)
  NCT04501406 · Phase: Phase 2 · Ages: 21 Years to 75 Years · Sex: All (male and female) · 2 locations
• Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
  NCT06657209 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · 2 locations
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · 1 location
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
  NCT02969798 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Quantifying Hepatic Mitochondrial Fluxes in Humans
  NCT05305287 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study Pioglitazone for Type 2 diabetes?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.